RecruitingNCT06042387

Genome Analysis Across Populations in Inflammatory Bowel Disease


Sponsor

Mount Sinai Hospital, Canada

Enrollment

150 participants

Start Date

May 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Objective: To use clinical, genetic and genome analysis to better understand and define the genetic and environmental factors that contribute to IBD within affected populations.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is analyzing genetic differences across diverse populations in people with inflammatory bowel disease (IBD) — including Crohn's disease and ulcerative colitis — to better understand why some groups are more affected than others and to improve treatments for everyone. **You may be eligible if...** - You have been diagnosed with Crohn's disease, ulcerative colitis, or another form of IBD - Your diagnosis can be confirmed through your medical records - You are any age - OR you are a healthy volunteer with no personal or family history of IBD **You may NOT be eligible if...** - You have other gastrointestinal conditions that do not meet the IBD or healthy control criteria Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICBlood or saliva sample collection

Blood or saliva sample \& clinical data collection


Locations(1)

Sinai Health System

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06042387


Related Trials